Comparing the Clinical Trial Characteristics of Industry-Funded Trials and Non Industry-Funded Trials

被引：0

作者：

Hughes, Emily ^{[1
]}

Van Bakel, Tamara ^{[2
]}

Raudanskis, Ashley ^{[1
]}

Ray, Prachi ^{[1
]}

Hodzic-Santor, Benazir ^{[1
]}

Purohit, Ushma ^{[1
]}

Sacks, Chana A. ^{[3
,4
]}

Fralick, Michael ^{[1
,2
]}

机构：

[1] Sinai Hlth Syst, Div Gen Internal Med, Toronto, ON, Canada

[2] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada

[3] Harvard Med Sch, Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA USA

[4] Harvard Med Sch, Massachusetts Gen Hosp, Mongan Inst, Boston, MA USA

来源：

JOURNAL OF LAW MEDICINE & ETHICS | 2024年 / 52卷 / 03期

关键词：

Randomized Controlled Trials; Funder; Trial Characteristics; Pharmaceutical; Industry; Natural Language Processing;

D O I：

10.1017/jme.2024.135

中图分类号：

B82 [伦理学（道德学）];

学科分类号：

摘要：

We compared study characteristics of randomized controlled trials funded by industry (N=697) to those not funded by industry (N=835). RCTs published in high-impact journals are more likely to be blinded, more likely to include a placebo, and more likely to post trial results on ClinicalTrials.gov. Our findings emphasize the importance of evaluating the quality of an RCT based on its methodological rigor, not its funder type.

引用

页码：693 / 700

页数：8

共 50 条

[1] Credibility of industry-funded clinical trials
Tohen, Mauricio
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (08): : 1879 - 1884
[2] Concerns regarding industry-funded trials
Meier, P
JOURNAL OF HUMAN LACTATION, 2005, 21 (02) : 121 - 123
[3] Industry-funded versus publicly funded trials: Are the standards the same?
Reynolds, T
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (21) : 1590 - 1592
[4] Phase IV Drug Trials With a Canadian Site: A Comparison of Industry-Funded and Non-Industry-Funded Trials
Lexchin, Joel
Dong, Blue Miaoran
Ramanathan, Aravind
Gagnon, Marc-Andre
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2024, 13
[5] Evaluation of investigator bias in industry-funded clinical trials of latanoprost
Jinapriya, Delan
Anraku, Ayako
Alasbali, Tariq
Trope, Graham E.
Buys, Yvonne M.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2011, 46 (06): : 531 - 536
[6] Developing a clinical trial governance framework for pharmaceutical industry-funded clinical trials
Nair, Satish Chandrasekhar
AlGhafli, Shamsa
AlJaberi, Ayesha
ACCOUNTABILITY IN RESEARCH-POLICIES AND QUALITY ASSURANCE, 2018, 25 (7-8): : 373 - 386
[7] Cochrane review questions value of industry-funded clinical trials
Hynes, Veronique
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2013, 185 (02) : E85 - E86
[8] Sharing of Data From Industry-Funded Registered Clinical Trials
Boutron, Isabelle
Dechartres, Agnes
Baron, Gabriel
Li, Jacques
Ravaud, Philippe
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (24): : 2729 - 2730
[9] Inclusion of pregnant or lactating individuals in industry-funded clinical trials
Khan, Amanda Lalita Harrilal
Melake, Abigail
Sahin, Leyla
Spong, Catherine
Yao, Lynne
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2025, 232 (03) : e83 - e88
[10] Research suggests presentation bias in industry-funded psychiatric clinical trials
Purslow, Caroline
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (07) : 761 - 761

← 1 2 3 4 5 →